Reaction

Infusion Site Pustule reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 125 reports · 3 co-occurring drugs

As of the last recalculation, Infusion Site Pustule appears in 125 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 1,047.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Treprostinil1081,047.41,048.3
Tadalafil42104.7104.7
Ambrisentan3052.352.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.